La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In vivo And NotA. J. Stoessl

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000258 JING GUO [République populaire de Chine] ; Jun-Kang Shen [République populaire de Chine] ; LAN WANG [République populaire de Chine] ; LI XIAO [République populaire de Chine] ; Rong-Jun Zhang [République populaire de Chine] ; Wei-Feng Luo [République populaire de Chine] ; Zhi-Gang Gong [République populaire de Chine] ; JING SUN [République populaire de Chine] ; HAN XU [République populaire de Chine] ; Pierre Sirois [Canada] ; KAI LI [République populaire de Chine]In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson's Disease Rats Using Magnetic Resonance Imaging
000351 Edor Kabashi [Canada] ; LI LIN [Canada] ; Miranda L. Tradewell [Canada] ; Patrick A. Dion [Canada] ; Valérie Bercier [Canada] ; Patrick Bourgouin [Canada] ; Daniel Rochefort [Canada] ; Samar Bel Hadj [Canada] ; Heather D. Durham [Canada] ; Christine Vande Velde [Canada] ; Guy A. Rouleau [Canada] ; Pierre Drapeau [Canada]Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo
000422 S. Bourgault [Canada, France] ; D. Vaudry [France] ; A. Dejda [Canada, France] ; N. D. Doan [Canada, France] ; H. Vaudry [France] ; A. Fournier [Canada, France]Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure-Activity Relationships of a Neuroprotective Peptide
000993 Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie]Role of serotonin2C receptors in the control of brain dopaminergic function
000A15 James E. Holden [États-Unis] ; Salma Jivan [Canada] ; Thomas J. Ruth [Canada] ; Doris J. Doudet [Canada]In vivo receptor assay with multiple ligand concentrations: An equilibrium approach
000A90 Hitoshi Shinotoh [Japon] ; Hiroki Namba [Japon] ; Mika Yamaguchi [Japon] ; Kiyoshi Fukushi [Japon] ; Shin-Ichiro Nagatsuka [Japon] ; Masaomi Iyo [Japon] ; Masato Asahina [Japon] ; Takamichi Hattori [Japon] ; Shuji Tanada [Japon] ; Toshiaki Irie [Japon]In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy
000A91 Toshiya Murai [Canada, Allemagne] ; Ulrich Müller ; Katja Werheid ; Dietlind Sorger ; Mike Reuter ; Thomas Becker ; D. Yves Von Cramon ; Henryk BarthelIn vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's Disease
000B96 M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada]Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS
000C64 E. M. Khalil [États-Unis] ; W. H. Ojala [États-Unis] ; A. Pradhan [Canada] ; V. D. Nair [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide
000D06 W. W. Martin [Canada] ; T. E. Roberts [Canada] ; F. Q. Ye [Canada] ; P. S. Allen [Canada]Increased basal ganglia iron in striatonigral degeneration : In vivo estimation with magnetic resonance
000D93 P. W. Baures [États-Unis] ; W. H. Ojala [États-Unis] ; W. J. Costain [Canada] ; M. C. Ott [Canada] ; A. Pradhan [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide
000E12 F. J. G. Vingerhoets [Canada] ; M. Schulzer ; T. J. Ruth ; J. E. Holden ; B. J. SnowReproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease
000E23 D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada]In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates
000E27 F. Q. Ye [Canada] ; W. R. M. Martin ; P. S. Allen [Canada]Estimation of brain iron in vivo by means of the interecho time dependence of image contrast
000E80 R. Kanthan [Canada] ; A. Shuaib ; G. Goplen ; H. MiyashitaA new method of in-vivo microdialysis of the human brain
001126 P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di PaoloBehavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022